Daclizumab Biosimilar - Research Grade
Daclizumab Biosimilar - Research Grade
Product Details:ichorbio's daclizumab biosimilar is for Research Use Only (RUO)
Size:ichorbio's RUO daclizumab biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of this biosimilar - please contact us for pricing.
Target:CD25
Isotype:IgG1
Other Names:Alpha subunit IL-2R, interleukin 2 receptor
Host:CHO cells
Species Reactivity:Human
Specificity:Detects human CD25.
Purification Method:This recombinant protein was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background:Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T-cells.
Concentration:1.0 - 5.0 mg/ml
Formulation:Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity:>95% by SDS-PAGE and HPLC
Endotoxin:≤ 1.0 EU/mg as determined by the LAL method
Storage:Daclizumab biosimilar - Research Grade is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Applications:Functional Assays
Application Notes:Each investigator should determine their own optimal working dilution for specific applications.
Isotype Control: Use: ichorbio's daclizumab biosimilar is for research use only (RUO).Concentration | 8.39mg/ml |
---|---|
isotype | IgG1 |
Host | CHO cells |